Medidata to Present at Citi 2016 Global Technology Conference

NEW YORK--(BUSINESS WIRE)-- Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that Mike Capone, chief operating officer, and Rouven Bergmann, chief financial officer, will present at the Citi 2016 Global Technology Conference on Tuesday, September 6, 2016, at 3:05 p.m. ET in New York.

A live audio webcast will be available on the “Investor” section of Medidata’s website at http://investor.mdsol.com. Please visit the website at least 15 minutes prior to the event to register, download and install any necessary audio or video software to access the presentation. For those unable to participate in the live webcast, a replay will be archived on the “Investor” section of Medidata’s website at http://investor.mdsol.com for a limited period of time following the conference.

About Medidata

Medidata is reinventing global drug development by creating the industry's leading cloud-based solutions for clinical research. Through our advanced applications and intelligent data analytics, Medidata helps advance the scientific goals of life sciences customers worldwide, including more than 700 global pharmaceutical companies, innovative biotech, diagnostic and device firms, leading academic medical centers, and contract research organizations.

The Medidata Clinical Cloud® (MCC) brings a new level of quality and efficiency to clinical trials that empower our customers to make more informed decisions earlier and faster. Our unparalleled clinical trial data assets provide deep insights that pave the way for future growth. The MCC® is the primary technology solution powering clinical trials for 17 of the world's top 25 global pharmaceutical companies, from study design and planning through execution, management and reporting.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160901005168/en/

Medidata Solutions
Investor:
Anthony D’Amico, +1 732-767-4331
[email protected]
or
Media:
Nicole Pariser, +1 212-659-1069
[email protected]

Source: Medidata

You May Also Be Interested In

• BPC HONOURED WITH THREE GLOBAL RECOGNITIONS AT THE GLOBAL BRAND AWARDS 2026
• Transgene to Present Preclinical Data Demonstrating Robust Protection Against Mpox with its Novel Scalable Cell Line–Derived MVA Vaccine Candidate (TG MVA(TM)) at WCID 2026
• WISeKey and SEALSQ Establish Quantisimo Corp. as a Special Purpose Vehicle, and Execute Letter of Intent with GigCapital8 Corp.